XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Adjustment
Common Stock
Additional paid in capital
Additional paid in capital
Adjustment
Accumulated other comprehensive income (loss)
Retained earnings
Retained earnings
Adjustment
Balance at beginning of period (in shares) at Dec. 31, 2021     16,767          
Balance at beginning of period at Dec. 31, 2021 $ 821,159 $ (15,997) $ 17 $ 372,969 $ (51,130) $ (917) $ 449,090 $ 35,133
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)     94          
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (5,515)     (5,515)        
Share-based compensation 9,044     9,044        
Unrealized net gain (loss) on available-for-sale securities, net of tax (114)         (114)    
Net Income (loss) (15,385)           (15,385)  
Balance at end of period (in shares) at Mar. 31, 2022     16,861          
Balance at end of period at Mar. 31, 2022 793,192   $ 17 325,368   (1,031) 468,838  
Balance at beginning of period (in shares) at Dec. 31, 2021     16,767          
Balance at beginning of period at Dec. 31, 2021 821,159 $ (15,997) $ 17 372,969 $ (51,130) (917) 449,090 $ 35,133
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Unrealized net gain (loss) on available-for-sale securities, net of tax (149)              
Net Income (loss) (16,280)           (16,280)  
Balance at end of period (in shares) at Jun. 30, 2022     16,882          
Balance at end of period at Jun. 30, 2022 802,365   $ 17 335,471   (1,066) 467,943  
Balance at beginning of period (in shares) at Mar. 31, 2022     16,861          
Balance at beginning of period at Mar. 31, 2022 793,192   $ 17 325,368   (1,031) 468,838  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)     21          
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes 604     604        
Share-based compensation 9,499     9,499        
Unrealized net gain (loss) on available-for-sale securities, net of tax (35)         (35)    
Net Income (loss) (895)           (895)  
Balance at end of period (in shares) at Jun. 30, 2022     16,882          
Balance at end of period at Jun. 30, 2022 $ 802,365   $ 17 335,471   (1,066) 467,943  
Balance at beginning of period (in shares) at Dec. 31, 2022 16,951   16,951          
Balance at beginning of period at Dec. 31, 2022 $ 597,485   $ 17 147,590   (984) 450,862  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)     183          
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (762)     (762)        
Share-based compensation 5,931     5,931        
Unrealized net gain (loss) on available-for-sale securities, net of tax 49         49    
Final distribution of OmniAb 1,665     1,665        
Net Income (loss) 41,949           41,949  
Balance at end of period (in shares) at Mar. 31, 2023     17,134          
Balance at end of period at Mar. 31, 2023 $ 646,317   $ 17 154,424   (935) 492,811  
Balance at beginning of period (in shares) at Dec. 31, 2022 16,951   16,951          
Balance at beginning of period at Dec. 31, 2022 $ 597,485   $ 17 147,590   (984) 450,862  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Unrealized net gain (loss) on available-for-sale securities, net of tax 17              
Net Income (loss) $ 44,239           44,239  
Balance at end of period (in shares) at Jun. 30, 2023 17,352   17,352          
Balance at end of period at Jun. 30, 2023 $ 664,892   $ 17 170,741   (967) 495,101  
Balance at beginning of period (in shares) at Mar. 31, 2023     17,134          
Balance at beginning of period at Mar. 31, 2023 646,317   $ 17 154,424   (935) 492,811  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)     218          
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes 9,110     9,110        
Share-based compensation 7,207     7,207        
Unrealized net gain (loss) on available-for-sale securities, net of tax (32)         (32)    
Net Income (loss) $ 2,290           2,290  
Balance at end of period (in shares) at Jun. 30, 2023 17,352   17,352          
Balance at end of period at Jun. 30, 2023 $ 664,892   $ 17 $ 170,741   $ (967) $ 495,101